 Tiziana Life Sciences NASDAQ: TLSA shares are trading higher by 16 at 2.10 as traders circulate a June 17 press release from the company titled Tiziana Responds to UK Call for Development of Innovative Take Home Treatments for COVID-19 Disease. Tiziana Life Sciences is a clinical-stage biotechnology company that specializes in developing transformative therapies for autoimmune and inflammatory diseases, degenerative diseases and cancer-related to the liver. 